Anna Borrelli
Pozzuoli, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A critical analysis on ENaC inhibitors, unravelling molecular medicinal insights and promising research roadmap in the treatment of cystic fibrosis.
Journal: European journal of medicinal chemistry
Published: February 27, 2026
Modulators of anion channels and transporters as alternative therapeutic agents to normalize airway surface liquid in cystic fibrosis.
Journal: European journal of medicinal chemistry
Published: July 09, 2025
Rescue of the CFTR chloride channel with nonsense mutations is markedly improved under inflammatory conditions.
Journal: The European respiratory journal
Published: June 09, 2025
Pharmacological rescue of the G85E CFTR variant by preclinical and approved modulators.
Journal: Frontiers in pharmacology
Published: September 10, 2024
Novel tricyclic pyrrolo-quinolines as pharmacological correctors of the mutant CFTR chloride channel.
Journal: Scientific reports
Published: October 23, 2022
Comprehensive Analysis of Combinatorial Pharmacological Treatments to Correct Nonsense Mutations in the CFTR Gene.
Journal: International journal of molecular sciences
Published: July 09, 2021
Partial Rescue of F508del-CFTR Stability and Trafficking Defects by Double Corrector Treatment.
Journal: International journal of molecular sciences
Published: March 11, 2021
TRPV4 and purinergic receptor signalling pathways are separately linked in airway epithelia to CFTR and TMEM16A chloride channels.
Journal: The Journal of physiology
Published: August 09, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026